Genitourinary Cancers Hub

Genitourinary Cancers Hub

Videos

b2ap3_large_ODA-Expert-Perspectives-Testicular-Cancer-Awareness-Month_960x800
b2ap3_large_Video-Expert-Perspectives-Kidney-Cancer-Awareness-Month_960x800
b2ap3_large_Video-Expert-Perspectives-Freedland-and-Aronson_960x800
Dr. Stephen Freedland and Dr. Neeraj Agarwal discuss the TALAPRO-2 study of talazoparib/enzalutamide in prostate cancer.
Dr. Stephen Freedland shares the significance of the approval of enzalutamide for prostate cancer with biochemical recurrence.
For the Great American Smokeout, Dr. Stephen Freedland discusses the link between smoking and prostate cancer.

News

HPV_causing_cervical_cancer-compressed
b2ap3_large_Histopathology_of_squamous_cell_carcinoma_of_the_urinary_bladder_high_magnification-compressed
b2ap3_large_HE_stained_section_of_adenocarcinoma_in_peritoneal_fluid-compressed
b2ap3_large_1280px-Plasmacytoid_urothelial_carcinoma_low_mag
The FDA approved enzalutamide for nonmetastatic castration-sensitive prostate cancer with biochemical recurrence at high risk for metastasis.
Niraparib and Abiraterone Acetate Plus Prednisone Approved for BRCA-Mutated Metastatic CRPC.

Podcasts

b2ap3_large_Podcast-Expert-Perspectives-Approval-of-Lifileucel-for-Melanoma_960x800
Dr. Stephen Freedland shares the significance of the approval of enzalutamide for prostate cancer with biochemical recurrence.
Tanya Dorff updates us on recent improvements and new data for the diagnosis and treatment of advanced prostate cancer.
For the Great American Smokeout, Dr. Stephen Freedland discusses the link between smoking and prostate cancer.
b2ap3_large_Podcast-Expert-Perspectives-Thomas-Powles-MD-MBBS-MRCP_960x800
b2ap3_large_Podcast-Expert-Perspectives-Prostate-Cancer-Awareness-Month_960x800-compressed